Search academic texts

Information × Registration Number 0300U002551, 0199U001556 , R & D reports Title Clinical, functional, immunological evaluation of the new pharmacological methods effectiveness in treatment of the widespread heart and vascular diseases (AH, atherosclerosis and CAD) popup.stage_title Вивчення впливу флавоноїдів на перебіг гострого Q-ІМ. Вивчення порівняльного впливу антагоністів кальцію, інгібіторів АУФ та статинів на перебіг постінфарктного періоду та подальший прогноз захворювання. Head Dzyak G.V., Registration Date 22-12-2000 Organization Dniepropetrovsk State Medical Academy popup.description2 Within the framework of work 80 patients with acute myocardial infarction are inspected. For the first time is carried out clinico-immunologic study of flavonoid corvitin at the patients in Q - myocardial infarction. Is established, that the new approach to the treatment of that pathology reduces in improving clinical symptoms, diminution of the center necrosis at the expense of suppression of production of cytotoxic metabolites by leukocytes and common slacking of the immune answer, that renders positive effect and on consequent current CAD and preservation of functional reserves of the myocardium. Besides 60 patients in Q- myocardial infarction with moderate essentials hypertension are inspected. From them 30 patients were offered during the 3-rd months for accepting diltiazem (180 mg/day), and the remaining 30 patients has made a control board. The condition hemodynamics and neurohumoral of a system, diurnal indexes variability of a rhythm of heart and their oscillation within day, influence of the carried out therapy to the prognosis of disease was studied. The factors of risk of development of complications, sudden death and unfavorable current of disease were determined. Is established, that the study variability of a rhythm of heart at the patients after transferred Q - myocardial infarction at early stages to predict development of complications of disease, and the 3-rd monthly therapy diltiazem till a comparison with a control board does not worsen these indexes. Product Description popup.authors popup.nrat_date 2020-04-03 Close